With the analysis among 1,035 patents, we discovered top 175 key players by total patent application. Amgen Research (Munich) GmbH, Amgen, Inc., NTG Nordic Transport Group A/S are dominant in this area. They take 22.32% of the total patent filing.
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 97
California, United States
Patent: 68
NTG Nordic Transport Group A/S
Araim Pharmaceuticals, Inc.
New York, United States
Patent: 41
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 29
Genève, Switzerland
Patent: 28
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 27
Washington, United States
Patent: 26
Centre of Molecular Immunology
Washington, United States
Patent: 24
With the analysis among 21 patents, we discovered top 6 start-ups by total patent application. Autolus Ltd., Institut National de la Santé et de la Recherche Médicale, Leto Laboratories Co., Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Leto Laboratories Co., Ltd.
Beijing Shi, China
Patent: 4
Bright Peak Therapeutics AG
Basel-Stadt, Switzerland
Patent: 4
Suzhou Kerui Gene Biotechnology Co. Ltd.
Jiangsu Sheng, China
Patent: 2
With the analysis among related 187 patents applied in the last 5 years. We discover 59 most active companies in this area. The fast-growing BioNTech SE, BioNTech Cell & Gene Therapies GmbH, Marshall University Research Corp. take 20.86% of patent filing during this period.
Rheinland-Pfalz, Germany
Patent: 15
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 12
Marshall University Research Corp.
West Virginia, United States
Patent: 12
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 12
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 10
Basel-Stadt, Switzerland
Patent: 9
BioNTech RNA Pharmaceuticals GmbH
Rheinland-Pfalz, Germany
Patent: 8
Tiziana Life Sciences Ltd. (United Kingdom)
WESTMINSTER, United Kingdom
Patent: 8
Chugai Pharmaceutical Co., Ltd.
With the analysis among related 187 patents in last 5 years, we discover 39 new entrants. BioNTech SE, BioNTech Cell & Gene Therapies GmbH, TRON - Translationale Onkologie an der Universitätsmedizin der are the most active new entrants in this area.
Rheinland-Pfalz, Germany
Patent: 15
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 12
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 10
Tiziana Life Sciences Ltd. (United Kingdom)
WESTMINSTER, United Kingdom
Patent: 8
BioNTech RNA Pharmaceuticals GmbH
Rheinland-Pfalz, Germany
Patent: 8
California, United States
Patent: 6
FUNDAMENTAL SOLUTIONS CORP
Bright Peak Therapeutics AG
Basel-Stadt, Switzerland
Patent: 4
With the analysis among 245 patents, we discovered top 32 universities and scientific research institutions by total patent application. University of Birmingham, The Garvan Institute of Medical Research, New York University are dominant in this area. They take 27.76% of the total patent filing.
Birmingham, United Kingdom
Patent: 13
The Garvan Institute of Medical Research
New South Wales, Australia
Patent: 10
New York, United States
Patent: 8
The University of Queensland
Queensland, Australia
Patent: 7
The Rockefeller University
New York, United States
Patent: 7
Rutgers State University of New Jersey
New Mexico, United States
Patent: 6
The Johns Hopkins University
undefined undefined
Patent: 5
Georgia, United States
Patent: 4
The Salk Institute for Biological Studies
California, United States
Patent: 4